CCL23 Antibodies

Santa Cruz Biotechnology delivers a wide array of CCL23 monoclonal antibodies for research focused on understanding CCL23's role in various biological processes. CCL23 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CCL23, also known as chemokine (C-C motif) ligand 23, plays a crucial role in the immune response by recruiting immune cells to inflammation sites. CCL23 has been linked to several pathological conditions, including autoimmune diseases and cancer, making it a significant target for therapeutic intervention. Research has shown that CCL23 expression patterns vary across different tissue types and disease states. Understanding CCL23's molecular interactions and signaling pathways can reveal new therapeutic strategies. Recent studies have highlighted CCL23's potential as a biomarker in various disease conditions. Investigating CCL23's function continues to provide valuable insights into immune regulation and disease progression. Santa Cruz Biotechnology monoclonal antibodies for CCL23 research support scientists worldwide in advancing our understanding of immune system regulation and disease mechanisms.